Skip to content

Jonathan Gillis, CAO and Interim CFO at MapLight Therapeutics, sold MPLT on Jul 15, 2026

Data as of Oct 16

▼ SELL$194K5,356 shares at $36.13Jonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.
Watch MPLT
Traded
Jul 15, 2026
Disclosed
Jul 20, 2026
Filed
5 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jonathan Gillis, CAO and Interim CFO at MapLight Therapeutics, sold MPLT on Jul 15, 2026TRADEDDISCLOSED
MPLTSimilar stocks (XLV — its sector index fund), rebased to MPLT's price on the disclosure day
MPLT since disclosure
−78.6%
after the sale
Similar stocks (XLV) since disclosure
+11.0%
XLV — its sector index fund

Change in closing price from Jul 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$21.9Kdisclosed Jul 20 · filed 3 days after the trade
  2. ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$638Kdisclosed Jul 20 · filed 3 days after the trade
  3. ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$34.4Kdisclosed Jul 20 · filed 3 days after the trade
  4. ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$256Kdisclosed Jul 20 · filed 4 days after the trade
  5. ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$55.3Kdisclosed Jul 20 · filed 4 days after the trade
  6. ▼ SELLJonathan Gillis CAO and Interim CFOMPLT MapLight Therapeutics, Inc.$174Kdisclosed Jul 20 · filed 5 days after the trade · late

See every trade on MPLT →